May 6, 2026

ABOUT THIS EPISODE

Matthew Rabinowitz, PhD, moved from engineering to medicine after his Human Genome Project work, motivated by both scientific insight and personal loss that exposed the limits of existing genetic diagnostics. He founded Natera and later Myome, building genomic and AI-driven tools to improve disease detection, risk assessment, and prevention. In the episode, he highlights challenges. such as regulatory barriers, fragmented data, and translating genetics into clinical decisions, while aiming to develop predictive blood tests that enable proactive care.

Produced and hosted by Jonathan D. Grinstein, PhD

Audio mixed and mastered by Erick Ziegler

Brought to you by Inside Precision Medicine (SAGE Publishing)

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Health & Fitness

Technology

Medicine

Science

English

United States

Use API to fetch this episode in JSON

IN THIS EPISODE

erick ziegler

matthew rabinowitz

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Behind the Breakthroughs.

Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Michael Antonov: From Virtual World Builder to Real-World Drug Designer

July 1, 2026

AI is transforming biomedical research, but meaningful advances in drug discovery require more than just increasingly powerful algorithms—they depend on combining machine learning with physics-based simulations, mechanistic models, and rigorous experimental validation. In this episode of Behind the…

01:02:09

SAVE

CLIP

Arthur Caplan: The Right to Life, Liberty, and Pursuit of Health

June 3, 2026

While growing up during the polio era, Arthur Caplan, PhD, saw doctors hide painful truths from families and children, which sparked his lifelong questions about power, protection, and inequality in medicine. In this episode, Caplan claims that bioethics has changed from marginalizing or abandoning…

01:00:54

SAVE

CLIP

Philippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders

June 17, 2026

Philippe Pouletty, MD, is one of Europe’s most successful life sciences entrepreneurs, having spent more than 30 years building category-leading biotechnology and medical technology companies from breakthrough scientific innovations. His most notable achievement is Abivax, which he founded and chai…

00:58:32

SAVE

CLIP

Carolina Aguilar: Brain-Computer Interfaces that Heal Neural Circuits

May 20, 2026

Brain-computer interfaces have gained widespread attention largely for assistive applications, but Carolina Aguilar sees their greatest potential in directly treating neurological disease. Through INBRAIN Neuroelectronics, she is developing graphene-based implants designed to read and stimulate neu…

00:54:44

SAVE

CLIP

Disclaimer: The podcast and artwork embedded on this page are from Inside Precision Medicine, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.